- Tytuł:
- Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
- Autorzy:
- Źródło:
- In The Breast October 2013 22(5):628-633
Czasopismo naukowe